Phaarmasia Limited (BOM:523620)
74.83
-0.37 (-0.49%)
At close: Mar 25, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 510.86 million as of March 27, 2026. Its market cap has increased by 65.77% in one year.
Market Cap
510.86M
Enterprise Value
506.56M
Revenue
449.06M
Ranking
n/a
PE Ratio
2.88
Stock Price
74.83
Market Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 510.86M, an increase of 3,628.32%. That is a compound annual growth rate of 13.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 510.86M | -33.63% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Godavari Drugs | 658.09M |
| Amwill Health Care | 640.92M |
| Asston Pharmaceuticals | 595.91M |
| Onyx Biotec | 562.10M |
| Shelter Pharma | 490.88M |
| Biofil Chemicals and Pharmaceuticals | 474.54M |
| Mangalam Drugs & Organics | 464.72M |
| Rajnish Wellness | 446.75M |